Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 01.06.2026 1 Am J Dermatopathol 3 Ann Surg Oncol 1 BMC Cancer 1 Cancer Res 1 Eur J Dermatol 1 J Am Acad Dermatol 1 J Immunol 1 J Invest Dermatol 2 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. TRIYANGKULSRI K, Wittayabusarakam N, Smitthisakda S, Sakpuwadol N, et al
   Diagnostic and Prognostic Values of PRAME Immunohistochemistry in Acral Lentiginous Melanoma.
   Am J Dermatopathol. 2026 May 27. doi: 10.1097/DAD.0000000000003305.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. AW K, Lau R, Wong B, Riad K, et al
   The Impact of a Regional Community of Practice to Improve Quality of Melanoma Care: Setting Guidelines for Preoperative Diagnostic Imaging in Early-Stage Melanoma.
   Ann Surg Oncol. 2026 May 29. doi: 10.1245/s10434-026-19847.
   PubMed         Abstract available
   
   
3. DEVIREDDY A, Yi Y, Nordlund KN, Lin R, et al
   The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis.
   Ann Surg Oncol. 2026 May 26. doi: 10.1245/s10434-026-19819.
   PubMed         Abstract available
   
   
4. LAWLESS A, Effiom DN, Burbano A, Sharova T, et al
   Personalization of Neoadjuvant Immunotherapy in High-Risk Resectable Melanoma and Utility of ctDNA as a Biomarker of Immunotherapy Response.
   Ann Surg Oncol. 2026 May 23. doi: 10.1245/s10434-026-19814.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. PACACI B, Erkan Ozmarasali B, Deligonul A, Gurbuz AF, et al
   Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.
   BMC Cancer. 2026 May 22. doi: 10.1186/s12885-026-16194.
   PubMed         Abstract available
   
   

   
   Cancer Res

6. SRIRAMAREDDY S, Siddarajappa N, Park JS, Nguyen T, et al
   GDF15 Reprograms the Microenvironment to Drive Liver Metastasis of Uveal Melanoma.
   Cancer Res. 2026 May 28. doi: 10.1158/0008-5472.CAN-25-0536.
   PubMed         Abstract available
   
   

   
   Eur J Dermatol

7. KLEISS MA, Goebeler M, Gesierich A, Uslu U, et al
   Rapid regression of a mucosal melanoma after a single dose of immune checkpoint inhibitors.
   Eur J Dermatol. 2026;36:208-210.
   PubMed        
   
   

   
   J Am Acad Dermatol

8. KIM DY, Swetter SM, Huhmann L, Ferguson JM, et al
   Sentinel Lymph Node Biopsy Utilization and Positivity in Veterans with Cutaneous Melanoma: A Comparative Analysis of the VA Cancer Registry and the SEER Program.
   J Am Acad Dermatol. 2026 May 25:S0190-9622(26)02735.
   PubMed        
   
   

   
   J Immunol

9. TURNQUIST A, Javaid A, Wilkins OM, Kolling Iv F, et al
   PI3Kdelta inhibition alters CD8 T cell differentiation and reprograms the tumor microenvironment following adoptive immunotherapy.
   J Immunol. 2026;215:vkag108.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

10. NAZIR ZH, Manci R, Nanda JK, Dusza SW, et al
    Diagnostic performance of electrical impedance spectroscopy in patients with multiple nevi and large acquired nevi.
    J Invest Dermatol. 2026;146:1628-1634.
    PubMed         Abstract available
    
    

    
    Melanoma Res

11. AKCAY P, Esen Baris M, Guven S, Yayla SB, et al
    Immune checkpoint inhibitor-associated uveitis in metastatic melanoma: case report and literature review.
    Melanoma Res. 2026 May 27. doi: 10.1097/CMR.0000000000001112.
    PubMed         Abstract available
    
    
12. CARRON J, Ferreira AMC, Carvalho BF, Lourenco GJ, et al
    CTLA-4 and TNFRSF1B genetic variants in clinicopathological aspects and outcome of cutaneous melanoma.
    Melanoma Res. 2026 May 27. doi: 10.1097/CMR.0000000000001108.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum